In the rapidly evolving field of inflammasome therapeutics, the need for innovative approaches to overcome the preclinical ...

During the pharma group's first-half results update, Jennifer Taubert, chair of J&J's worldwide innovation group, said that ...

Gilead Sciences' chief medical officer, Merdad Parsey, will leave the company in early 2025, becoming the latest in a series ...

The House Committee on Oversight and Accountability will quiz leaders of pharmacy benefit managers (PBMs) at a hearing next ...

When it comes to life sciences manufacturing, there's nothing quite so daunting as a tech transfer - moving a product from ...

Boehringer Ingelheim has joined forces with digital health firm Brainomix on a project to improve the care of people with ...

The hearing – scheduled for 23rd July – is part of an ongoing investigation by the committee into PBMs' alleged ...

The key health points have been welcomed by the NHS Confederation, which also said it was encouraged by proposals to give ...

James Burt, CEO of Pharmanovia, is a seasoned leader focused on driving innovation in the value-added medicines (VAMs) space.

Some of these areas of particular importance to pharma include helping accelerate drug discovery, clinical trials, and more ...

Roche has reported early-stage clinical data with an oral GLP-1 agonist acquired as part of its $3.1 billion takeover of ...